Experimental validation of a theoretical model of cytokine capture using a hemoadsorption device.
Sepsis, a systemic inflammatory response in the presence of an infection, is characterized by overproduction of inflammatory mediators called cytokines. Removal of these cytokines using an extracorporeal hemoadsorption device is a potential therapy for sepsis. We are developing a cytokine adsorption device (CAD) filled with microporous polymer beads and have previously published a mathematical model which predicts the time course of cytokine removal by the device. The goal of this study was to show that the model can experimentally predict the rate of cytokine capture associated with key design and operational parameters of the CAD. We spiked IL-6, IL-10, and TNF into horse serum and perfused it through an appropriately scaled-down CAD and measured the change in concentration of the cytokines over time. These data were fit to the mathematical model to determine a single model parameter, Gamma( i ), which is only a function of the cytokine-polymer interaction and the cytokine effective diffusion coefficient in the porous matrix. We compared Gamma( i ) values, which by definition should not change between experiments. Our results indicate that the Gamma( i ) value for a specific cytokine was statistically independent of all other parameters in the model, including initial cytokine concentration, flow rate, serum reservoir volume, CAD size, and bead size. Our results also indicate that competitive adsorption of cytokines and other middle-molecular weight proteins, which is neglected in the model, does not affect the rate of removal of a given cytokine. The model of cytokine capture in the CAD developed in this study will be integrated with a systems model of sepsis to simulate the progression of sepsis in humans and to develop a therapeutic CAD design and intervention protocol that improves patient outcomes in sepsis.
DiLeo
Morgan V
MV
McGowan Institute for Regenerative Medicine, University of Pittsburgh, 215 McGowan Institute, 3025 East Carson Street, Pittsburgh, PA 15203, USA. dileomv@upmc.edu
Fisher
James D
JD
Federspiel
William J
WJ
D003198:Computer Simulation; D017076:Computer-Aided Design; D016207:Cytokines / Q000097:blood* / Q000302:isolation & purification*; D004867:Equipment Design; D019544:Equipment Failure Analysis; D006440:Hemofiltration / Q000295:instrumentation* / Q000379:methods*; D006801:Humans; D008955:Models, Cardiovascular; D008956:Models, Chemical; D014462:Ultrafiltration / Q000295:instrumentation / Q000379:methods
D016207:Cytokines
Blood Purif. 2004;22(5):428-34
15316198
J Chromatogr A. 1999 Dec 31;865(1-2):155-68
10674938
Crit Care Med. 2001 Jul;29(7):1303-10
11445675
Crit Care Med. 2001 Mar;29(3):671-2
11373443
Ann Biomed Eng. 2009 Jan;37(1):222-9
18949559
J Phys Chem B. 2006 Jan 26;110(3):1429-36
16471694
Crit Care. 2002 Oct;6(5):429-33
12398783
Crit Care Med. 2008 May;36(5):1573-7
18434884
J Theor Biol. 2008 Aug 21;253(4):843-53
18550083
Chest. 1992 Jun;101(6):1644-55
1303622
Minerva Anestesiol. 1999 Jun;65(6):410-8
10394812
Microcirculation. 2006 Mar;13(2):111-8
16459324
Arch Intern Med. 2007 Aug 13-27;167(15):1655-63
17698689
J Biol Chem. 1968 Aug 10;243(15):4095-103
4175239
Crit Care Med. 1993 Apr;21(4):522-6
8472571
Ann Intern Med. 2003 Mar 18;138(6):502-5
12639085
Arch Surg. 1997 Jul;132(7):703-7
9230852
Nat Med. 1997 Nov;3(11):1193-5
9359687
J Chromatogr A. 2004 Sep 10;1048(2):161-72
15481253
Crit Care Med. 2004 Mar;32(3):801-5
15090965
Crit Care Med. 1997 Jul;25(7):1095-100
9233726